ADPT · Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.
1165 EASTLAKE AVENUE EAST, SEATTLE, WA, UNITED STATES, 98109, Seattle, WA, 98109, USA
DIAGNOSTICS & RESEARCH
HEALTHCARE
Market Cap
3.999B
52 Wk Range
$12.00 - $30.74
Previous Close
$25.06
Open
$25.46
Volume
1,512,841
Day Range
$25.32 - $26.46
Enterprise Value
4.318B
Cash
169.9M
Avg Qtr Burn
-6.40M
Insider Ownership
1.29%
Institutional Own.
N/A
Qtr Updated
Jun 30th 2026